Pharma R&D Services Market Forecast to Grow at 5% p.a., Reaching ~$129B by 2029 – Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC, a leading market intelligence and strategy consulting firm, announced the publication of its first edition, “Pharma R&D Services Market Report (2024-2029).” This comprehensive report forecasts the global pharma R&D services market to reach approximately $129 billion by 2029, growing at a compound annual growth rate (CAGR) of 5% from an estimated $101 billion in 2024.
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 10% p.a., Reaching $2.1B by 2029 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Single-Cell Analysis (SCA): Market Size, Segmentation, Growth, Competition, and Trends (2024-2029),” the global single-cell analysis market is predicted to reach $2.1B by 2029. This growth will be driven by broader adoption across both biopharma and academia, falling costs enabling higher throughput experiments, and increasing use of newer assays, particularly those supporting FFPE- and multomics-based analysis.
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 29% p.a., Reaching $10.1B by 2029 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Oncology Liquid Biopsy (LBx) Market Report 2024 – 2029,” the global oncology liquid biopsy market is predicted to reach $10.1B by 2029, driven by a broad push for increased biomarker testing globally, updated testing guidelines, and expansion in coverage for testing.
DeciBio Forecasts the Spatial Biology Market, Growing at 21% p.a. to Reach $2.27B in 2029 - Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC’s latest market report, “Spatial Biology Market Report, Second Edition: 2024-2029,” states that the global spatial biology market is predicted to reach $2.27B by 2029.
DeciBio Forecasts the Rise of Allogeneic Therapies to Fuel the Worldwide Cell Therapy R&D and Manufacturing Market, Growing at 21% p.a. to Reach $14.5B by 2028 - Market Report by DeciBio Consulting LLC
DeciBio Consulting LLC’s latest market report, “Cell Therapy Manufacturing Global Market Report, First Edition: 2023-2028,” states that the global cell therapy manufacturing market, driven by innovation in manufacturing tools and the number of expected approvals in the near-term, is predicted to reach $14.5B by 2028.
Worldwide Single Cell Analysis (SCA) Market Forecasted to Grow at 13% p.a. over the Next Three Years, Reaching $1.7B by 2025 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, Single-Cell Analysis (SCA): Market Size, Segmentation, Growth, Competition, and Trends (2019-2025), the global single-cell analysis market is predicted to reach $1.7B by 2025. This growth will be driven by expansion in new applications and offerings, such as FFPE-compatibility and instruments for low- and high-throughput customers.
Worldwide NGS Market Forecasted to Grow at 15% p.a., to Reach ~$9.3B in 2025 – Market Report by DeciBio Consulting
DeciBio Consulting LLC’s latest market report, “Next Generation Sequencing (NGS) Market Size, Growth and Trends (2019-2025),” predicts that the Next generation Sequencing market will grow to ~$9.3 billion (USD) in 2025 driven primarily by clinical adoption in oncology settings across the patient journey, including early detection and monitoring.
Worldwide Spatial Biology Market Forecasted to Grow at 30% p.a., Reaching ~$1.2B by 2027 – Market Report by DeciBio Consulting
DeciBio Consulting LLC’s latest market report, “DeciBio Spatial Biology Market Report 2022,” states that the global spatial biology market — driven by steady growth in academia and accelerated growth in biopharma and CROs, particularly within clinical trials — is predicted to reach $1.2B by 2027.
Worldwide Liquid Biopsy (LBx) Market Forecasted to Grow at 46% p.a., Reaching $8.6B by 2027 – Market Report by DeciBio Consulting LLC
According to a comprehensive market report authored by DeciBio Consulting LLC, “Oncology Liquid Biopsy (LBx) Market Report 2022 - 2027,” the global oncology liquid biopsy market, driven by growth in new applications – primarily minimum residual disease (MRD) testing, serial monitoring, and early cancer detection – is predicted to reach $8.6B by 2027.
